A complex healthcare-cost problem, made obvious to institutional capital.

$17MSeries B led by Aquiline, Dec 2024

$42Mtotal capital raised

Situation

Scripta Insights helps employers, health plans and members cut prescription-drug costs by surfacing lower-cost alternatives and pharmacy options. With real operating traction, it was approaching a major institutional financing and needed its market opportunity, economics and growth case to be easy to underwrite.

JetPack's role

01Capital strategyShaped the capital-facing strategy and investor narrative ahead of the Series B process.
02Investor presentationBuilt and refined the presentation around market opportunity, differentiation, traction and growth.
03One-page collateralCreated supporting one-page investor materials.
04LegibilityTurned a complex healthcare-cost problem into a story institutional capital could follow.

Outcome

Scripta Insights announced a $17M Series B in December 2024, led by Aquiline, bringing total capital raised to $42M.

Capabilities

Value Proposition & PositioningHow we work Financial & Operational ReadinessHow we work Investor & Diligence ReadinessHow we work

References available on request.

Next case: SOSA / NYC Global Cyber Center

Preparing to raise?

If the story, numbers or diligence process aren't where they need to be yet, that's where we come in.

Discuss your raise

30-minute intro callMatan Magril, Founder & CEO

Commitment-free consultation
The same senior team, start to finish
A reply within one business day